TMBIM1: Potential Cancer Drug Target (G64114)

Target Name: TMBIM1

NCBI ID: G64114

TMBIM1

TMBIM1: Potential Cancer Drug Target

TMBIM1 (Tumor membranous membrane protein-1) is a protein that is expressed in various tissues, including the skin, hair, and nails, and has been identified as a potential drug target in the field of cancer. The LFG3 gene, which encodes for TMBIM1, has been associated with the development and progression of various cancers, including skin and cervical cancers.

TMBIM1 has been shown to play a role in cell signaling pathways, including the TGF-β pathway. This pathway is involved in cell growth, differentiation, and survival, and is a key factor in the development of cancer. TMBIM1 has been shown to be involved in the regulation of TGF-β signaling by interacting with the protein SMAD4.

In addition to its role in cell signaling pathways, TMBIM1 has also been shown to be involved in the regulation of cellular adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and is a critical factor in the development and maintenance of tissues and organs. TMBIM1 has been shown to be involved in the regulation of adhesion by interacting with the protein E-cadherin.

TMBIM1 has also been shown to be involved in the regulation of cell migration. Cell migration is the process by which cells move from one location to another in the body, and is a critical factor in the development and treatment of cancer. TMBIM1 has also been shown to be involved in the regulation of cell migration by interacting with the protein vimentin.

In conclusion, TMBIM1 is a protein that has been shown to play a role in various cellular processes that are involved in the development and progression of cancer. As a potential drug target, TMBIM1 is a promising target for the development of new treatments for a variety of cancers. Further research is needed to fully understand the role of TMBIM1 in cancer development and to develop effective treatments.

Protein Name: Transmembrane BAX Inhibitor Motif Containing 1

Functions: Negatively regulates aortic matrix metalloproteinase-9 (MMP9) production and may play a protective role in vascular remodeling

The "TMBIM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMBIM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets